Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 9/20 | 0.43 |
| ▸ | KDM5A | P29375 | 7/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KDM5C | P41229 | 1/20 | 0.42 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.41 |
| ▸ | KDM4A | O75164 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10337349 | 0.93 | EPHX2 (0.57) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL7940018 | 0.93 | ALDH1A1 (0.65) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL14747420 | 0.91 | EPHX2 (0.60) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL516247 | 0.91 | EPHX2 (0.60) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL9692935 | 0.91 | EPHX2 (0.60) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL736629 | 0.91 | EPHX2 (0.60) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL117447 | 0.91 | EPHX2 (0.60) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL114380 | 0.91 | EPHX2 (0.60) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL20673423 | 0.91 | ALDH1A1 (0.62) | ALDH1A1EPHX2CNR1CES1CES2 | |
| SCHEMBL13773023 | 0.88 | EPHX2 (0.62) | ALDH1A1EPHX2CNR1CES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630731-B2 | Non-aqueous ink composition | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-05-07 | — | — | US | disclosed |
| US-12590216-B2 | Water-based ink and ink set including same | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12522744-B2 | Ink set | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| US-20250368766-A1 | RESIN, RESIN DISPERSION, AND RESIN COMPOSITION | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-12-04 | — | — | US | disclosed |
| EP-4617333-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP Fine Chemicals Co., Ltd. (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-20250236749-A1 | NON-AQUEOUS INK COMPOSITION | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-07-24 | — | — | US | disclosed |
| EP-4549524-A1 | AQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATTER, RECORDED MATTER, AND INKJET RECORDING DEVICE | DNP Fine Chemicals Co., Ltd. (JP) | 2025-05-07 | — | — | EP | disclosed |
| EP-4549474-A1 | RESIN, RESIN DISPERSION, AND RESIN COMPOSITION | DNP Fine Chemicals Co., Ltd. (JP) | 2025-05-07 | — | — | EP | disclosed |
| US-20250043140-A1 | NON-AQUEOUS INK COMPOSITION, INK SET, RECORDING METHOD USING SAME, METHOD FOR PRODUCING RECORDED MATTER, RECORDED MATTER, AND INKJET RECORDING APPARATUS | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-02-06 | — | — | US | disclosed |
| WO-2023120521-A1 | NON-AQUEOUS INK COMPOSITION | 株式会社ＤＮＰファインケミカル | 2023-06-29 | — | — | WO | disclosed |
| WO-2023067126-A1 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| EP-4169580-A1 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | BioNTech SE (DE) | 2023-04-26 | — | — | EP | disclosed |
| WO-2023276973-A1 | OVERCOAT INK AND INK SET CONTAINING SAME | 株式会社ＤＮＰファインケミカル | 2023-01-05 | — | — | WO | disclosed |
| WO-2023276974-A1 | OVERCOAT INK AND INK SET INCLUDING SAME | 株式会社ＤＮＰファインケミカル | 2023-01-05 | — | — | WO | disclosed |
| WO-2023276979-A1 | WATER-BASED INK AND INK SET INCLUDING SAME | 株式会社ＤＮＰファインケミカル | 2023-01-05 | — | — | WO | disclosed |
| WO-2023276978-A1 | PRETREATMENT INK AND INK SET CONTAINING SAME | 株式会社ＤＮＰファインケミカル | 2023-01-05 | — | — | WO | disclosed |
| WO-2022186280-A1 | INK SET | 株式会社ＤＮＰファインケミカル | 2022-09-09 | — | — | WO | disclosed |
| US-10981900-B2 | Spiro compound and use thereof | MEDSHINE DISCOVERY INC. (CN) | 2021-04-20 | — | — | US | disclosed |
| US-20200048235-A1 | SPIRO COMPOUND AND USE THEREOF | MEDSHINE DISCOVERY INC. (CN) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048235-A1 | SPIRO COMPOUND AND USE THEREOF | S1PR1, S1PR2, S1PR3 | ALDH1A1 862/4885EPHX2 1559/4885CNR1 17/4885 |
| US-12630731-B2 | Non-aqueous ink composition | EXOSC10, RPP30, RPS20 | ALDH1A1 1893/4885EPHX2 4211/4885CNR1 4829/4885 |
| US-12590216-B2 | Water-based ink and ink set including same | TYR, ITGB3, ARCN1 | ALDH1A1 1130/4885EPHX2 1122/4885CNR1 4868/4885 |
| US-10981900-B2 | Spiro compound and use thereof | S1PR1, S1PR2, S1PR3 | ALDH1A1 862/4885EPHX2 1559/4885CNR1 17/4885 |
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | BMI1, IK, PRDM9 | ALDH1A1 333/4885EPHX2 3385/4885CNR1 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.